NJNicolas Jaccard

Nicolas Jaccard

*This is an algorithmically generated author record based on publicly available information.

Nicolas Jaccard has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic Accuracy of Cybersight AI for Glaucoma Detection: Sensitivity, Specificity, and ROC Analysis

    by Nha Uyen Phan, Trong Van Pham, Kim Thanh Doan, Le Phuc Hoang, Nhu Vinh Tuyen Pham, Minh Tuan Nguyen, Quoc Tung Mai, Nicolas Jaccard, Nathan Congdon

    Glaucoma is a chronic, progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Early detection is crucial but is often limited by nonspecific clinical signs and the need for specialist expertise. Artificial intelligence (AI), particularly deep learning, has shown promise for glaucoma detection from ophthalmic images. This study independently validated an existing third-party AI tool, Cybersight AI, powered by the Visulytix Pegasus engine, for detecting primary glaucoma. No new algorithm was developed or proposed. A cross-sectional diagnostic accuracy study was conducted on 229 eyes from 121 patients, including 133 eyes with primary glaucoma and 96 controls, at Hue Central Hospital between December 2024 and September 2025. Fundus photographs were analyzed using the Cybersight AI platform, which estimated the vertical cup-to-disc ratio and generated a binary glaucoma referral recommendation. AI outputs were compared with diagnoses established by ophthalmologists using an expert multimodal clinical reference standard. Diagnostic performance was assessed using sensitivity, specificity, positive and negative predictive values, and the area under the receiver operating characteristic curve (AUC). At its default operating point, Cybersight AI achieved 51.9% sensitivity (95% CI 43.5–60.2) and 90.6% specificity (95% CI 83.1–95.0), with an AUC of 0.744 (95% CI 0.682–0.807). Positive and negative predictive values were 88.5% and 57.6%, respectively. The Youden-optimal cut-off was 10%, yielding 60.9% sensitivity and 85.4% specificity. Cybersight AI demonstrated moderate discrimination, high specificity, and modest sensitivity at its default binary setting in this Vietnamese tertiary-care cohort. It may serve as a screening or triage adjunct, although context-specific thresholding and further external validation are required before broad clinical deployment. Limitations include the single-center convenience sample, within-patient clustering, and comparison of a fundus-only index test against a multimodal reference standard. Future studies should prioritize multicenter validation in Vietnamese settings and comparison with expert fundus assessment alone.

  • Open Access

    Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda

    by Noelle Whitestone, John Nkurikiye, Jennifer L Patnaik, Nicolas Jaccard, Gabriella Lanouette, David H Cherwek, Nathan Congdon, Wanjiku Mathenge

    Background Evidence on the practical application of artificial intelligence (AI)-based diabetic retinopathy (DR) screening is needed. Methods Consented participants were screened for DR using retinal imaging with AI interpretation from March 2021 to June 2021 at four diabetes clinics in Rwanda. Additionally, images were graded by a UK National Health System-certified retinal image grader. DR grades based on the International Classification of Diabetic Retinopathy with a grade of 2.0 or higher were considered referable. The AI system was designed to detect optic nerve and macular anomalies outside of DR. A vertical cup to disc ratio of 0.7 and higher and/or macular anomalies recognised at a cut-off of 60% and higher were also considered referable by AI. Results Among 827 participants (59.6% women (n=493)) screened by AI, 33.2% (n=275) were referred for follow-up. Satisfaction with AI screening was high (99.5%, n=823), and 63.7% of participants (n=527) preferred AI over human grading. Compared with human grading, the sensitivity of the AI for referable DR was 92% (95% CI 0.863%, 0.968%), with a specificity of 85% (95% CI 0.751%, 0.882%). Of the participants referred by AI: 88 (32.0%) were for DR only, 109 (39.6%) for DR and an anomaly, 65 (23.6%) for an anomaly only and 13 (4.73%) for other reasons. Adherence to referrals was highest for those referred for DR at 53.4%. Conclusion DR screening using AI led to accurate referrals from diabetes clinics in Rwanda and high rates of participant satisfaction, suggesting AI screening for DR is practical and acceptable.


  • Open Access

    Segmentation of phase contrast microscopy images based on multi-scale local Basic Image Features histograms

    by N. Jaccard, N. Szita, L.D. Griffin

    Phase contrast microscopy (PCM) is routinely used for the inspection of adherent cell cultures in all fields of biology and biomedicine. Key decisions for experimental protocols are often taken by an operator based on typically qualitative observations. However, automated processing and analysis of PCM images remain challenging due to the low contrast between foreground objects (cells) and background as well as various imaging artefacts. We propose a trainable pixel-wise segmentation approach whereby image structures and symmetries are encoded in the form of multi-scale Basic Image Features local histograms, and classification of them is learned by random decision trees. This approach was validated for segmentation of cell versus background, and discrimination between two different cell types. Performance close to that of state-of-the-art specialised algorithms was achieved despite the general nature of the method. The low processing time ( < 4 s per 1280 × 960 pixel images) is suitable for batch processing of experimental data as well as for interactive segmentation applications.